Descubra las mejores clínicas y precios para el tratamiento de Esclerosis múltiple en India 2026

Multiple Sclerosis is treatable in India through advanced disease-modifying therapies and specialized neuro-rehabilitation. Leading JCI-accredited centers in Delhi, Mumbai, and Bengaluru offer modern infusions like Ocrelizumab. Treatment focus remains on managing relapses and slowing progression using international medical protocols and diagnostic imaging.

• Treatment approaches: Clinics offer disease-modifying therapies, plasmapheresis, and specialized MS rehabilitation.
• Advanced procedures: High-dose corticosteroids and Hematopoietic Stem Cell Transplantation (HSCT) treat severe cases.
• Expert neurologists: Specialists like Dr. Hitesh Kumar at Artemis Hospitals provide comprehensive care.
• Accredited facilities: Clinics like Manipal and Apollo Indraprastha hold JCI and NABH accreditations.

Bookimed Expert Insight: While many believe specialized care is limited to the capital, Manipal Hospitals in Bengaluru serves 2 million patients annually across a massive 15-hospital network. This scale allows them to maintain consistent stocks of newer disease-modifying therapies that are often unavailable in smaller regional centers.

Patient Consensus: Patients emphasize that getting diagnosed in major metropolitan hospitals is faster than in government facilities. Many note the importance of joining support groups to find affordable generic medication suppliers and active clinical trials.

Advanced Multiple Sclerosis treatments like Hematopoietic Stem Cell Transplantation (HSCT) in India show success rates between 80% and 90% for halting disease progression. Outcomes are highest for Relapsing-Remitting Multiple Sclerosis (RRMS) patients. Indian centers utilize global auto-SCT protocols within Joint Commission International (JCI) accredited facilities.

• Remission rates: RRMS patients often achieve 80% to 85% long-term remission after treatment.
• Disease stabilization: Top medical centers report 80% success in stopping further neurological damage.
• Patient age: Clinical outcomes are significantly better for patients under 45 years old.
• Early intervention: Success reaches 62.5% in early stages versus 23.6% in late-stage disease.

Bookimed Expert Insight: While many focus on Delhi or Mumbai, Apollo Hospital Indraprastha in Delhi stands out as the largest transplantation center outside the USA. This high volume is a critical quality signal. Data shows centers performing more transplants typically manage post-chemotherapy recovery more effectively, which is vital for MS patients whose primary risk is infection during the 3-month recovery window.

Patient Consensus: Patients note that while the procedure is life-changing, intense chemotherapy side effects require strict isolation. Many emphasize tracking baseline MRI data carefully to measure long-term success accurately.

India offers advanced Multiple Sclerosis treatment at JCI-accredited facilities in Delhi, Mumbai, and Gurgaon. Leading centers like Artemis Hospitals and Apollo Hospital Indraprastha provide specialized neuroimaging, plasma exchange, and monoclonal antibody therapies. These hospitals integrate neurology with multidisciplinary rehabilitation for comprehensive patient care.

• Specialized technology: Centers utilize 3T MRI and advanced neuro-operating theatres for precise monitoring.
• Treatment range: Protocols include Ocrevus infusions, Rituximab generics, plasmapheresis, and bone marrow transplants.
• Accreditation standards: Top facilities hold JCI and NABH certifications ensuring international safety protocols.
• Expert access: Systems like the Full Time Specialist System ensure constant neurology consultant availability.

Bookimed Expert Insight: Patient volume data highlights a significant gap in service speed between private and public sectors. While AIIMS Delhi is a premier research center, private networks like Manipal Hospitals serve over 2,000,000 patients annually with significantly shorter wait times. Choosing a facility in the Manipal or Apollo network often ensures quicker access to critical infusions like Ocrevus compared to the typical 6-month wait in public institutions.

Patient Consensus: Patients note that private clinics in Mumbai and Bangalore offer faster access to diagnostic tests like evoked potentials. Many emphasize joining local support groups to find the most affordable pricing for high-quality generic medications.

India provides a diverse range of recognized complementary treatments through the Ministry of AYUSH. These therapies include Ayurveda, Yoga, Naturopathy, Unani, Siddha, and Homeopathy. While not curative for multiple sclerosis, they serve as adjunctive care to manage symptoms alongside conventional neurological treatments.

• Ayurvedic therapy: Uses herbal formulations and Panchakarma for managing fatigue and pain.
• Yoga practices: Employs Hatha and adaptive yoga to improve balance and spasticity.
• Medical integration: Many JCI-accredited hospitals co-locate AYUSH facilities for holistic patient care.
• Specialized rehabilitation: Centers like Artemis Hospitals offer neuro-rehabilitation to support physical recovery.
• Cellular therapy: Some clinics offer NK cell therapy as an emerging alternative approach.

Bookimed Expert Insight: Patients often overlook that India's largest medical networks, such as Manipal or Apollo, provide access to 1,900+ doctors. This scale allows patients to combine advanced neurology with recognized alternative medicine in one city. Choosing a facility with both JCI and NABH accreditations ensures that complementary therapies meet international safety standards.

Patient Consensus: Patients emphasize that while Ayurveda and Yoga help significantly with mental health and mobility, they must never replace disease-modifying therapies. Many note that Vitamin D and B12 supplementation is essential in India due to high local deficiency rates.

The Indian government supports MS patients through the Rights of Persons with Disabilities Act 2016. This provides legal recognition and workplace protection. Patients can access subsidized care at AIIMS and through the Central Government Health Scheme. Financial aid primarily comes from state-specific welfare programs and NGOs.

• Disability benefits: Patients with a UDID card receive tax deductions and employment protection.
• Hospital subsidies: National institutes provide low-cost consultations and acute relapse treatments for citizens.
• State insurance: Schemes like Ayushman Bharat cover hospitalization costs for eligible low-income families.
• Welfare programs: Regions like Kerala and Maharashtra offer targeted medicine reimbursement and pensions.

Bookimed Expert Insight: While national drug subsidies are limited, top private centers like Manipal Hospitals and Apollo Indraprastha offer advanced diagnostics like MRI and CT. Private facilities often provide faster access to specialized neurologists like Dr. Hitesh Kumar. Patients at these JCI-accredited hubs can access multidisciplinary care that smaller government centers may lack.

Patient Consensus: Patients note that government aid is often patchy and mostly covers basic mobility aids. Many suggest applying for state disability certificates immediately to secure monthly pensions and potential medication discounts.